ACL SNNAP Trial: ACL Surgery Necessity in Non Acute Patients (ACL SNNAP)

October 14, 2021 updated by: University of Oxford

Comparison of the Clinical and Cost Effectiveness of Two Management Strategies for Non-acute Anterior Cruciate Ligament (ACL) Injury: Rehabilitation Versus Surgical Reconstruction.

The primary objective of this study is to determine in patients with non-acute Anterior Cruciate Ligament Deficiency (ACLD) whether a strategy of non-surgical management [Rehabilitation] (with option for later ACL reconstruction, only if required) is more clinically effective and cost effective than a strategy of surgical management [Reconstruction].

Study Overview

Detailed Description

The ACL SNNAP study is a pragmatic multi-centre randomised controlled trial with two-arm parallel groups and 1:1 allocation ratio to compare non-surgical management (Rehabilitation) and surgical management (Reconstruction) options for patients with a symptomatic non-acute ACL deficient knee.

The objective is to determine, in patients with non-acute Anterior Cruciate Ligament Deficiency (ACLD), whether non-surgical treatment (with the option for later ACL reconstruction if required) is more effective than surgical ACL reconstruction (as measured by the Knee Injury and Osteoarthritis Outcome Score [KOOS4] at 18 months from randomisation).

Target sample size is 320 patients recruited from approx. 30 NHS orthopaedic units.

An internal pilot will be conducted with clear progression criteria regarding recruitment.

Both interventions are routine NHS treatments. Intervention content is based on a minimal set of pre-established criteria in order to ensure the integrity of the comparison while allowing for varying in practice in delivering the interventions between both surgeons and physiotherapists. This largely pragmatic approach will allow clinical management to reflect current practice and resource use within the NHS thus aiding generalisation.

Other than the allocated intervention, both groups will be followed-up in the same way to exclude bias. Follow up for study purposes will be by patient self-reported questionnaire completed using an electronic data capture collection system (a postal option will also be available). The questionnaire will include the outcomes indicated in section 4 and will be completed by participants at baseline, 6, 12 and 18 months. Non-response will be minimised through use of multiple reminders such as web based, phone and text.

Neither participants nor health care practitioners (surgeons and physiotherapists) can be blinded to receipt of the intervention.

Study Type

Interventional

Enrollment (Anticipated)

320

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Bangor, United Kingdom
        • Recruiting
        • Betsi Cadwaladr University Health Board
      • Basildon, United Kingdom
        • Recruiting
        • Basildon and Thurrock University Hospitals NHS Foundation Trust
        • Contact:
          • Sean Symons
      • Bristol, United Kingdom
        • Recruiting
        • North Bristol NHS Trust
        • Contact:
          • James Murray
      • Cheltenham, United Kingdom
        • Recruiting
        • Gloucestershire Hospitals NHS Foundation Trust
      • Chester, United Kingdom
        • Recruiting
        • Countess Of Chester Hospital NHS Foundation Trust
        • Contact:
          • Raghuram Thonse
      • Coventry, United Kingdom
        • Recruiting
        • University Hospitals Coventry and Warwickshire NHS Trust
      • Frimley, United Kingdom
        • Recruiting
        • Frimley Health NHS Foundation Trust
      • Guildford, United Kingdom
        • Recruiting
        • Royal Surrey County Hospitals NHS Foundation Trust
        • Contact:
          • Oliver Templeton-Ward
      • Hull, United Kingdom
        • Recruiting
        • Hull and East Yorkshire Hospitals NHS Trust
        • Contact:
          • Reza Mayahi
      • Leeds, United Kingdom
        • Recruiting
        • Leeds Teaching Hospitals NHS Trust
      • Leicester, United Kingdom
        • Recruiting
        • University Hospitals of Leicester
      • London, United Kingdom
        • Recruiting
        • University College London Hospitals NHS Foundation Trust
      • London, United Kingdom
        • Recruiting
        • Kings College Hospital NHS Foundation Trust
        • Contact:
          • Barry Andrews
      • Manchester, United Kingdom
        • Recruiting
        • Manchester University NHS Foundation Trust
        • Contact:
          • Pankaj Sharma
      • Oxford, United Kingdom
        • Recruiting
        • Oxford University Hospitals Nhs Foundation Trust
      • Peterborough, United Kingdom
        • Recruiting
        • North West Anglia NHS Foundation Trust
      • Portsmouth, United Kingdom
        • Recruiting
        • Portsmouth Hospitals NHS Trust
        • Contact:
          • Jeremy Rushbrook
      • Reading, United Kingdom
        • Recruiting
        • Royal Berkshire NHS foundation trust
      • Salisbury, United Kingdom
        • Recruiting
        • Salisbury NHS Foundation Trust
        • Contact:
          • Leonidas Vachtsevanos
      • Sheffield, United Kingdom
        • Recruiting
        • Sheffield Teaching Hospitals NHS Foundation Trust
      • Slough, United Kingdom
        • Recruiting
        • Frimley Health NHS Foundation Trust
      • Stockport, United Kingdom
        • Recruiting
        • Stockport NHS Foundation Trust
        • Contact:
          • David Johnson
      • Sutton In Ashfield, United Kingdom
        • Recruiting
        • Sherwood Forest Hospitals NHS Foundation Trust
      • Swansea, United Kingdom
        • Recruiting
        • Abertawe Bro Morannwg University Health Board
      • Swindon, United Kingdom
        • Recruiting
        • Great Western Hospitals NHS Foundation Trust
      • Taunton, United Kingdom
        • Recruiting
        • Taunton and Somerset NHS Foundation Trust
        • Contact:
          • Andrew Kelly
      • Truro, United Kingdom
        • Recruiting
        • Royal Cornwall Hospitals NHS Trust
        • Contact:
          • Robin Kincaid
      • Wakefield, United Kingdom
        • Recruiting
        • The Mid Yorkshire Hospitals NHS Trust
        • Contact:
          • Jon Smith
      • Warrington, United Kingdom
        • Recruiting
        • Warrington and Halton Hospitals NHS Foundation Trust
      • Wigan, United Kingdom
        • Recruiting
        • Wrightington, Wigan and Leigh NHS Foundation Trust
        • Contact:
          • Ben Coupe
      • Wrexham, United Kingdom
        • Recruiting
        • Betsi Cadwaladr University Health Board
        • Contact:
          • Yeogesh Joshi
      • Yeovil, United Kingdom
        • Recruiting
        • Yeovil District Hospital NHS Foundation Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 97 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Participant is willing and able to give informed consent for participation in the study.
  • Male or Female, aged 18 years or above.
  • Symptomatic ACL deficiency of the native ligament1 (instability-episodes of frank giving way or feeling unstable) with ACL deficiency (either partial or complete tear) confirmed using clinical assessment and MRI scan.

Exclusion Criteria:

  • Acute phase of primary ACL injury i.e. not recovered from any acute symptoms relating to their initial ACL injury.
  • Previous knee surgery (other than diagnostic arthroscopy or partial meniscectomy) to index knee concomitant severe injury to contra-lateral knee.
  • Meniscal pathology with characteristics that indicate immediate surgery i.e. locked knee, large bucket handle or complex cartilage tear producing mechanical symptoms.
  • Knee joint status of grade 3 or 4 on the Kellgren and Lawrence scale,
  • Grade 3 MCL/LCL injury, associated PCL/PLC injury
  • Inflammatory arthropathy.
  • Pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ACL Rehabilitation Group
Non-surgical management [Rehabilitation] with option for later Anterior Cruciate Ligament (ACL) reconstruction, only if required.
Routine ACL rehabilitation protocols used at the participating site will be followed. As part of the site selection process, documentary evidence of the use of or willingness to adopt a rehabilitation protocol that reflects the guidelines of the mandatory aims/goals set for the study rehabilitation intervention will be required.
Other Names:
  • Physiotherapy
  • Physical Therapy
  • Conservative Rehabilitation
  • Conservative Management
Active Comparator: ACL Reconstruction Group
Surgical Management - Anterior Cruciate Ligament (ACL) reconstruction surgery
All surgical reconstructions will be patella tendon or hamstrings tendon depending on the surgeon's preference. All other care will be routine, including immediate post-operative care.
Other Names:
  • ACL Reconstruction
  • ACLR
  • ACL surgery
  • Anterior Cruciate Ligament Surgery
  • Surgical Management

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Injury and Osteoarthritis Outcome Score (KOOS4)
Time Frame: 18 months post randomisation
The score is derived from 4 of 5 subscales; pain, symptoms, difficulty in sports and recreational activities, knee related quality of life.
18 months post randomisation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Time Frame: At baseline and at 6, 12 and 18 months post randomisation

All 5 subscales of the KOOS will be included (the fifth scale being activities of daily living).

Anterior Cruciate Ligament Quality of Life Score (ACL-QOL)

At baseline and at 6, 12 and 18 months post randomisation
Modified Tegner scale
Time Frame: At baseline and at 6, 12 and 18 months post randomisation
Activity level will be assessed using the Modified Tegner scale, graded from 1 (low activity levels) to 10 (professional level).
At baseline and at 6, 12 and 18 months post randomisation
Intervention related complications
Time Frame: At 6, 12 and 18 months post randomisation
Any complications associated with undergoing ACL deficiency treatment will be recorded. This includes; for surgery group; re-admission, delayed hospital discharge, infection, unexpected poor range of movement (stiffness), excess bleeding, continued swelling, episodes of giving way, continued feeling of instability. For non-surgical group; continued swelling, episodes of giving way.
At 6, 12 and 18 months post randomisation
EuroQol EQ-5D-5L
Time Frame: At baseline and at 6, 12 and 18 months post randomisation
Generic quality of life (self-reported outcome measure covering 5 health domains and used to facilitate the calculation of Quality Adjusted Life Years in health economic evaluations).
At baseline and at 6, 12 and 18 months post randomisation
Resource-usage data
Time Frame: 18 months post randomisation
Detailed resource use data on initial treatments received (surgical reconstruction or rehabilitation) and on subsequent healthcare contacts including re-operations (surgery arm), subsequent surgical reconstructions (rehabilitation arm), surgery-related complications, further rehabilitation, and primary care and other secondary care contacts out to 18 months post-randomisation. In addition, data will be collected on ability to work (e.g. sickness absences/return to work number of days off work and subjective working ability).
18 months post randomisation
Anterior Cruciate Ligament Quality of Life score (ACL-QOL)
Time Frame: At baseline and at 6, 12 and 18 months post randomisation
Expectations of return to activity and confidence in relation to the knee.
At baseline and at 6, 12 and 18 months post randomisation
Patient satisfaction
Time Frame: At baseline and at 6, 12 and 18 months post randomisation
Simple Likert scale
At baseline and at 6, 12 and 18 months post randomisation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2016

Primary Completion (Anticipated)

November 1, 2021

Study Completion (Anticipated)

March 1, 2022

Study Registration Dates

First Submitted

November 17, 2016

First Submitted That Met QC Criteria

November 29, 2016

First Posted (Estimate)

December 2, 2016

Study Record Updates

Last Update Posted (Actual)

October 15, 2021

Last Update Submitted That Met QC Criteria

October 14, 2021

Last Verified

November 1, 2020

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anterior Cruciate Ligament Injury

Clinical Trials on Non-Surgical Management (Rehabilitation)

3
Subscribe